Background: Cell transplantation to replace lost neurons in neurodegenerative diseases
such as Parkinson's disease (PD) offers a hopeful prospect for many patients. Previously …

Motor djsfunctions in Parkinson's disease a· e believed to be primarily due to the
degeneration of dopamincrgic neurons located in the substantia nigra pars compacta …

Parkinson disease (PD) is a neurological movement disorder resulting primarily from
damage to and degeneration of the nigrostriatal dopaminergic pathway. The pathway …

Parkinson's disease (PD) is the second most common neurodegenerative disorder after
Alzheimer's disease and it is characterized by the progressive loss of dopaminergic neurons …

Current findings suggest that multipotent stem cells may be suitable for cell replacement
therapies in the treatment of neurodegenerative disorders. Embryonic stem (ES) cells are …

Parkinson's disease (PD) manifests with a typical movement disorder, due to the loss of
dopaminergic neurons of the substantia nigra. There are no disease-modifying treatments …

Parkinson's disease (PD) is the most common movement disorder. The neuropathology is
characterized by the loss of dopamine neurons in the substantia nigra pars compacta …

Parkinson's disease (PD) is one of the most frequent neurodegenerative diseases and
represents a major therapeutic challenge because of the so far missing therapeutic means …

Parkinson's disease (PD) is a neurodegenerative condition characterized by the loss of
midbrain dopaminergic neurons, leading to motor symptoms. While current treatments …

Current approaches to cell replacement therapy in Parkinson's disease are strongly focused
on the dopamine system, with the view that restoring dopaminergic inputs in a localized and …